Application of radiosensitizers in cancer radiotherapy
L Gong, Y Zhang, C Liu, M Zhang… - International journal of …, 2021 - Taylor & Francis
Radiotherapy (RT) is a cancer treatment that uses high doses of radiation to kill cancer cells
and shrink tumors. Although great success has been achieved on radiotherapy, there is still …
and shrink tumors. Although great success has been achieved on radiotherapy, there is still …
Cancer radiosensitizers
Radiotherapy (RT) is a mainstay treatment for many types of cancer, although it is still a
large challenge to enhance radiation damage to tumor tissue and reduce side effects to …
large challenge to enhance radiation damage to tumor tissue and reduce side effects to …
Understanding and targeting the disease‐related RNA binding protein human antigen R (HuR)
Altered gene expression is a characteristic feature of many disease states such as
tumorigenesis, and in most cancers, it facilitates cancer cell survival and adaptation …
tumorigenesis, and in most cancers, it facilitates cancer cell survival and adaptation …
Cancer the 'RBP'eutics–RNA-binding proteins as therapeutic targets for cancer
RNA-binding proteins (RBPs) play a critical role in the regulation of various RNA processes,
including splicing, cleavage and polyadenylation, transport, translation and degradation of …
including splicing, cleavage and polyadenylation, transport, translation and degradation of …
[HTML][HTML] Redox regulation in tumor cell epithelial–mesenchymal transition: Molecular basis and therapeutic strategy
Epithelial–mesenchymal transition (EMT) is recognized as a driving force of cancer cell
metastasis and drug resistance, two leading causes of cancer recurrence and cancer …
metastasis and drug resistance, two leading causes of cancer recurrence and cancer …
[HTML][HTML] RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer
Traditionally majority of eukaryotic gene expression is influenced by transcriptional and post-
transcriptional events. Alterations in the expression of proteins that act post-transcriptionally …
transcriptional events. Alterations in the expression of proteins that act post-transcriptionally …
Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment
Co-administration of functionally distinct anti-cancer agents has emerged as an efficient
strategy in lung cancer treatment. However, a specially designed drug delivery system is …
strategy in lung cancer treatment. However, a specially designed drug delivery system is …
Posttranscriptional upregulation of IDH1 by HuR establishes a powerful survival phenotype in pancreatic cancer cells
Cancer aggressiveness may result from the selective pressure of a harsh nutrient-deprived
microenvironment. Here we illustrate how such conditions promote chemotherapy …
microenvironment. Here we illustrate how such conditions promote chemotherapy …
[HTML][HTML] Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy
In this study, we report the efficacy of RGD (arginine-glycine-aspartic acid) peptide-modified
polylactic acid-co-glycolic acid (PLGA)-Chitosan nanoparticle (CSNP) for integrin αvβ3 …
polylactic acid-co-glycolic acid (PLGA)-Chitosan nanoparticle (CSNP) for integrin αvβ3 …
[HTML][HTML] RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC
SJ Kim, JS Ju, MH Kang, JE Won, YH Kim… - Theranostics, 2020 - ncbi.nlm.nih.gov
Breast cancer (BC) is one of the most common cancers in women. TNBC (Triple-negative
breast cancer) has limited treatment options and still lacks viable molecular targets, leading …
breast cancer) has limited treatment options and still lacks viable molecular targets, leading …